These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8950801)

  • 1. von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
    Nesbitt IM; Goodeve AC; Preston FE; Peake IR
    Thromb Haemost; 1996 Nov; 76(5):820-1. PubMed ID: 8950801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Mazurier C; Meyer D
    Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arginine vasopressin (AVP) infusions on circulating concentrations of platelet AVP, factor VIII: C and von Willebrand factor.
    Nussey SS; Bevan DH; Ang VT; Jenkins JS
    Thromb Haemost; 1986 Feb; 55(1):34-6. PubMed ID: 3085262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variant type von Willebrand disease with defective binding to factor VIII].
    Shima M
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534
    [No Abstract]   [Full Text] [Related]  

  • 9. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X; Gabriel DA
    Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W).
    Bowen DJ; Standen GR; Mazurier C; Gaucher C; Cumming A; Keeney S; Bidwell J
    Thromb Haemost; 1998 Jul; 80(1):32-6. PubMed ID: 9684781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.
    Ebberink EH; Bouwens EA; Bloem E; Boon-Spijker M; van den Biggelaar M; Voorberg J; Meijer AB; Mertens K
    Haematologica; 2017 Apr; 102(4):686-694. PubMed ID: 28057741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII structure and function.
    Fay PJ
    Thromb Haemost; 1993 Jul; 70(1):63-7. PubMed ID: 8236116
    [No Abstract]   [Full Text] [Related]  

  • 15. [High plasma levels of factor VIII and von Willebrand factor in a patient with portal vein thrombosis].
    Günther R; Fölsch UR
    Z Gastroenterol; 2002 Jun; 40(6):409-12. PubMed ID: 12055664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL; Shi Q; Montgomery RR
    Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis in von Willebrand disease.
    Franchini M; Targher G; Lippi G
    Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.